Inventor · disambiguated record
Nikita Kotlov
Also filed as: KOTLOV NIKITA
15 granted patents·12 pending applications·82 citations·filing 2018–2024
93Inventor score
Files withBOSTONGENE CORP27
Top patents by PatentIndex Score
27 records- 0197US11302420B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Apr 12, 2022·8 cites·30 claims
- 0297US10580517B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Mar 3, 2020·11 cites·30 claims
- 0397US10311967B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 4, 2019·25 cites·25 claims
- 0495US11373733B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2020·Granted Jun 28, 2022·3 cites·20 claims
- 0595US10650911B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 12, 2020·8 cites·11 claims
- 0695US10395761B1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2019·Granted Aug 27, 2019·9 cites·30 claims
- 0792US11367509B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Jun 21, 2022·4 cites·21 claims
- 0891US10720230B2Method for administering a checkpoint blockade therapy to a subjectBOSTONGENE CORP·Filed 2018·Granted Jul 21, 2020·4 cites·9 claims
- 0991US10706954B2Systems and methods for identifying responders and non-responders to immune checkpoint blockade therapyBOSTONGENE CORP·Filed 2019·Granted Jul 7, 2020·3 cites·16 claims
- 1090US11430545B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted Aug 30, 2022·2 cites·23 claims
- 1190US11322226B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 3, 2022·2 cites·16 claims
- 1290US2024290434A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 1383US2022389512A1Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 1482US11984200B2Systems and methods for generating, visualizing and classifying molecular functional profilesBOSTONGENE CORP·Filed 2018·Granted May 14, 2024·1 cites·20 claims
- 1577US11482301B2Gene expression analysis techniques using gene rankings and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2020·Granted Oct 25, 2022·1 cites·33 claims
- 1674US11568959B2Tumor microenvironment-based methods for assessing CAR-T and other immunotherapiesBOSTONGENE CORP·Filed 2021·Granted Jan 31, 2023·1 cites·4 claims
- 1771US2025125013A1Hierarchical machine learning techniques for identifying molecular categories from expression dataBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 1868US2022375543A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 1968US2024379188A1Techniques for single sample expression projection to an expression cohort sequenced with another protocolBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2067US2024029884A1Techniques for detecting homologous recombination deficiency (hrd)BOSTONGENE CORP·Filed 2023·Application pending·0 cites
- 2166US2023073731A1Gene expression analysis techniques using gene ranking and statistical models for identifying biological sample characteristicsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2264US2025029677A1Techniques for identifying her2-low breast cancer tumorsBOSTONGENE CORP·Filed 2024·Application pending·0 cites
- 2363US2022307088A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2463US2022223227A1Machine learning techniques for identifying malignant b- and t-cell populationsBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 2560US2022290254A1B cell-enriched tumor microenvironmentsBOSTONGENE CORP·Filed 2022·Application pending·0 cites
- 2660US2022186318A1Techniques for identifying follicular lymphoma typesBOSTONGENE CORP·Filed 2021·Application pending·0 cites
- 2759US12254961B2Hierarchical machine learning techniques for identifying molecular categories from expression dataBOSTONGENE CORP·Filed 2021·Granted Mar 18, 2025·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Nikita Kotlov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →